Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients

INTRODUCTION: Subclinical inflammation is an important predictor of death-censored graft loss, and its treatment has been shown to improve graft outcomes. Urine CXCL10 outperforms standard post-transplant surveillance in observational studies, by detecting subclinical rejection and early clinical re...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Open
Päätekijät: Ho, Julie, Sharma, Atul, Kroeker, Kristine, Carroll, Robert, De Serres, Sacha, Gibson, Ian W, Hirt-Minkowski, Patricia, Jevnikar, Anthony, Kim, S Joseph, Knoll, Greg, Rush, David N, Wiebe, Chris, Nickerson, Peter
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2019
Aiheet:
Renal Medicine
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500325/
https://ncbi.nlm.nih.gov/pubmed/30975673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-024908
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia